Liberty TripAdvisor Holdings, Inc.: Nasdaq/NYSE listing notice — Liberty TripAdvisor receives Nasdaq bid price deficiency notice for LTRPA; 180-day cure period until Oct 18, 2023

Liberty TripAdvisor Holdings, Inc.

Nasdaq notified LTRPA closed below $1.00 for 30 consecutive business days as of Apr 21, 2023.
Initial 180-day compliance period until Oct 18, 2023 to regain minimum $1.00 bid price.
If not cured, may apply to transfer LTRPA to Nasdaq Capital Market for additional 180-day period.
Company monitoring options; no decision on response yet and cannot assure compliance.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Liberty TripAdvisor Holdings, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5450(a)(1), 5810(c)(3)(A)

Exact text from the filing

April 21, 2023, Liberty TripAdvisor Holdings, Inc. (the “Company”) received written notice (the “Notice”) from The Nasdaq Stock Market (“Nasdaq”) notifying the Company that, because the closing bid price for the Company’s Series A common stock, par value $0.01 per share (“LTRPA”), has fallen below $1.00 per share for 30 consecutive business days, the Company no longer complies with the minimum bid price requirement for continued listing of LTRPA on the Nasdaq Global Select Market. Nasdaq Listing Rule 5450(a)(1) requires listed securities to maintain a minimum bid price of $1.00 per share (the

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001606745-23-000013

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.